Stay updated on Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Sign up to get notified when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.

Latest updates to the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page
- CheckyesterdayChange DetectedAn updated Revision tag to v3.6.3 is now shown on the page, replacing the previous v3.6.2. This represents a minor release update to the site metadata and does not alter study data or page functionality.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision version v3.6.2 appears in the record history, replacing the previous v3.6.0, indicating an updated iteration of the study record history page.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew provenance fields 'Last verified' and 'Last known status was' were added to the study record history, and the revision label updated to v3.6.0. These changes clarify when a version was last checked and its status, enhancing version-tracking context.SummaryDifference3%

- Check30 days agoChange DetectedA new revision entry v3.5.5 was added to the study's record history and the previous revision v3.5.4 was removed, indicating an administrative update to the record.SummaryDifference0.1%

- Check51 days agoChange DetectedThe Record History now shows a new revision (v3.5.4) replacing the previous v3.5.3, reflecting an update to the page's revision history. This change does not modify the visible study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page’s revision/version label has been updated (v3.5.2 → v3.5.3) for the ClinicalTrials.gov record history display, without changing the underlying study record information shown.SummaryDifference0.1%

Stay in the know with updates to Novel CAR-T Cells for Hematological Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel CAR-T Cells for Hematological Malignancy Clinical Trial page.